PRODUCTION OF THERAPEUTIC ANTIBODIES
About the Proyect
Building a new industrial biotechnology facility for the production of monoclonal antibodies for therapeutic use for cancer and other non-transmissible chronic diseases, from the active pharmaceutical ingredient to the final drug form. Production is fundamentally for exportation.
Sector:
Biotechnology
Modality of Investment:
Joint Venture
Cuban Part:
CIMAB S.A.
Investment Amount:
70 millon USD
Location:
Contact Information
Name:
Elizabeth Arias Valdés
Position:
General Director
Email:
elizabeth@cimab.cu
corporate@cimab.cu
Phone:
(53) 72725164
(53) 72715057
(53)52146027